The Future of Pharmaceutical Drug Development in the Age of Precision Medicine
American Journal of Pharmaceutics · 30.06.2025 · 6 (3) · 13-24
DOI: 10.71465/ajph2741 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Pharmaceutics, online erschienen am 30.06.2025. Verfasst von Dr. John Smith. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The future of pharmaceutical drug development is being increasingly shaped by precision medicine, which tailors treatment to individual genetic profiles. This paradigm shift offers a more targeted and effective approach to treating diseases, particularly cancer, cardiovascular diseases, and rare genetic disorders. By leveraging genetic, environmental, and lifestyle data, precision medicine promises to enhance drug efficacy and minimize adverse effects. This article explores the evolution of pharmaceutical drug development, the integration of precision medicine into drug discovery and design, and the challenges and opportunities this approach presents.
Zitieren
APA
Smith, D. J. (2025). The Future of Pharmaceutical Drug Development in the Age of Precision Medicine. American Journal of Pharmaceutics, 6(3), 13-24. https://doi.org/10.71465/ajph2741
Vancouver
Smith DJ. The Future of Pharmaceutical Drug Development in the Age of Precision Medicine. American Journal of Pharmaceutics. 2025;6(3):13-24. doi:10.71465/ajph2741
BibTeX
@article{Smith2025,
author = {Smith, Dr. John},
title = {The Future of Pharmaceutical Drug Development in the Age of Precision Medicine},
journal = {American Journal of Pharmaceutics},
year = {2025},
volume = {6},
number = {3},
pages = {13--24},
doi = {10.71465/ajph2741}
}
EUVIMED